Paul Rowland - Concepedia

Author

Paul Rowland

GlaxoSmithKline (United Kingdom)

Also Known As

P Rowland, P. Rowland, P. Rowland, III, Paul Rowland

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)University of Copenhagen University of Edinburgh Centre for Inflammation Research GlaxoSmithKline (France)

About

Paul Rowland is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, biochemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	27	2.4K
2	Biochemistry	18	20	1.2K
3	Natural Sciences	16	18	1K
4	Allergy	3	3	191
5	Biomolecular Engineering	2	2	38

Paul Rowland

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response Laurens Kruidenier, Chun‐wa Chung, Zhongjun Cheng, Nature InflammationCytokineInflammatory DiseaseAutoimmune DiseaseAutophagy	2012	932
Crystal Structure of Human Cytochrome P450 2D6 Paul Rowland, Frank E. Blaney, Martin G. Smyth, Journal of Biological Chemistry	2005	432
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition Susan Wyllie, Stephen Brand, Michael G. Thomas, Proceedings of the National Academy of Sciences	2019	165
Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis Damian J. Mole, Scott P. Webster, Iain Uings, Nature Medicine InflammationAcute PancreatitisPancreatic CancerMedicineLiver Physiology	2016	155
The three–dimensional structure of glucose 6–phosphate dehydrogenase from Leuconostoc mesenteroides refined at 2.0 Å resolution Paul Rowland, Ajit K. Basak, S. Gover, Structure Aldo-keto ReductaseCellular EnzymologyBiochemistryBioenergeticsNatural Sciences	1994	132
Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease Kenneth Down, Augustin Amour, Ian T. Baldwin, Journal of Medicinal Chemistry AsthmaAcute Lung InjuryPi3kδ PotencyInflammatory Lung DiseaseLung Inflammation	2015	130
Active Site of Dihydroorotate Dehydrogenase A from <i>Lactococcus lactis</i> Investigated by Chemical Modification and Mutagenesis Olof Björnberg, Paul Rowland, Sine Larsen, Biochemistry	1997	100
The crystal structure of the flavin containing enzyme dihydroorotate dehydrogenase A from Lactococcus lactis Paul Rowland, F. S. NIELSEN, Kaj Frank Jensen, Structure Crystal StructureBiochemistryEnzyme CatalysisProtein X-ray CrystallographyStructure-function Enzyme Kinetics	1997	99
N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3 Richard Angell, Francis Atkinson, Murray J. B. Brown, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineRational Drug DesignDrug DevelopmentPharmacology	2006	90
Glucose 6-phosphate dehydrogenase mutations causing enzyme deficiency in a model of the tertiary structure of the human enzyme CE Naylor, Paul Rowland, A. K. Basak, Blood	1996	83

Page 1